cephalosporin c has been researched along with Borrelia hermsii Infection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbour, AG; Dever, LL; Jorgensen, JH; Kazragis, RJ | 1 |
Bode, U; Fleischhack, G; Hartmann, C; Hasan, C; Havers, W; Marklein, G; Simon, A; Wulff, B | 1 |
1 trial(s) available for cephalosporin c and Borrelia hermsii Infection
Article | Year |
---|---|
Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer.
Topics: Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Escherichia coli; Female; Fever; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Male; Meropenem; Neoplasms; Neutropenia; Prospective Studies; Relapsing Fever; Thienamycins; Time Factors; Treatment Outcome | 2001 |
1 other study(ies) available for cephalosporin c and Borrelia hermsii Infection
Article | Year |
---|---|
In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.
Topics: Animals; Anti-Bacterial Agents; Borrelia; Borrelia burgdorferi Group; Brain; Ceftriaxone; Cephalosporins; Injections, Subcutaneous; Lyme Disease; Mice; Mice, Inbred BALB C; Mice, SCID; Microbial Sensitivity Tests; Relapsing Fever; Vancomycin | 1996 |